<DOC>
	<DOCNO>NCT00460733</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety risedronate sodium ( ActonelÂ® ) wrist fracture postmenopausal woman .</brief_summary>
	<brief_title>SOLID-Effect Risedronate Sodium Distal Radius Colle 's Fracture .</brief_title>
	<detailed_description />
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Colles ' Fracture</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>Women description 2 year Menopause ; Tscore &lt; = 2.0 sd ; Confirmed colles'fracture ; Independent march ( preserve ambulatorial ability ) ; Comorbidities ; Regular use corticosteroid antiresorptive drug last year ; Use drug affect calcium metabolism ; Hypersensitivity risedronate ; Previous wrist forearm fracture ; Hypocalcemia ; Renal insufficiency ; Rheumatic disease ; The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>